Two schematic illustration of the human norovirus, in its resting and rising...
Human norovirus is an icosahedral virus approximately 40 nm in diameter. Its virus-like particle (VLP) consists of a shell (S) domain and a protruding (P) domain that extends from the shell. In the rising state, the P domain is elevated by approximately 1 nm relative to the "resting" state from the "rising" state (red arrow). The color scale represents the particle radius.

Image source: NIST; credit: Kazuyoshi Murata 

News • Study explores conformational plasticity

Shape-shifting: the key to norovirus infectiousness?

Cryo-electron microscopy captures structural changes that may influence viral infection

Human norovirus is the leading cause of acute gastroenteritis worldwide and is estimated to infect 600–700 million people each year. Despite its enormous public health impact, no effective antiviral drugs are currently available. A detailed understanding of the three-dimensional structure of the virus is essential for elucidating its infection mechanism and developing effective therapeutics. However, research on human norovirus has been hampered by the inability to efficiently propagate the virus in cultured cells, making it difficult to obtain sufficient quantities of infectious particles for structural studies. In contrast, studies of murine norovirus, which can readily be propagated in cell culture, have shown that its capsid undergoes conformational changes in response to environmental conditions. Whether human norovirus exhibits similar structural dynamics has remained unknown. 

To address this question, a research team led by the National Institutes of Natural Sciences in Japan and Pusan National University in South Korea successfully produced virus-like particles (VLPs) of the human norovirus GII.3 strain, which has been responsible for repeated regional outbreaks, and determined their structures using state-of-the-art cryo-electron microscopy (cryo-EM). Structural analysis revealed that a single VLP preparation contained two distinct conformational states, referred to as the resting and rising states, which differ in the location of the protruding (P) domain (see top figure). 

The researchers published their findings in the International Journal of Molecular Sciences. 

In the resting state, the P domain is held close to the shell through...
In the "resting" state, the P domain is held close to the shell through intermolecular interactions (red asterisk) between the P2 subdomains of neighboring capsid proteins. In the "rising" state, the P domain rotates and moves upward, and these interactions are replaced by new intermolecular contacts (red asterisk) between the P1 subdomains, which stabilize the elevated conformation.

Image source: NIST; credit: Kazuyoshi Murata

Further analysis showed that: 

  • In the resting state, the P domain is positioned close to the underlying shell (S) domain and forms an extensive interaction network mediated primarily by the distal P2 subdomain. 
  • In the rising state, the P domain is elevated by approximately 1 nm and rotated by about 55°, accompanied by a reorganization of the interaction network to the P1 subdomain (second figure). In addition, the P domain in the rising state exhibits substantially greater structural flexibility than in the resting state. 

These findings provide the first evidence that the human norovirus capsid, like that of murine norovirus, is not a rigid shell but a dynamic molecular assembly capable of adopting multiple conformations in response to its environment. Because the P domain contains both the host receptor-binding sites and the major antibody epitopes, these conformational changes may play important roles in regulating viral infectivity, receptor recognition, and immune evasion. 

Future studies will investigate the environmental factors—such as pH, metal ions, and physiological acids—that trigger these structural transitions, determine whether the same conformational changes as shown in murine norovirus occur in infectious virions, and explore the development of antibodies or small-molecule compounds capable of stabilizing or inhibiting these transitions. Such studies are expected to provide a foundation for the development of next-generation vaccines and novel antiviral therapies against human norovirus. 


Source: National Institutes of Natural Sciences 

06.08.2026

Related articles

Photo

News • ‘Reverse genetics’ system

New approach to norovirus vaccine and drug development

Researchers from Osaka have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines.

Photo

News • Neuroprotective antiviral state in the CNS

Remarkable early warning system helps the brain prepare for a viral attack

Virus-associated molecules in the foot are enough to trigger the network: Research reveals a remarkable mechanism, in which the brain prepares for a potential viral attack within hours of infection.

Photo

News • Infection prevention

Needle-free ‘universal vaccine’ could protect from future virus outbreaks

A research team has developed a way to engineer better vaccines that could provide broad protection from thousands of variants of viruses - such as coronaviruses or Ebola - in a single vaccine.

Subscribe to Newsletter